Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Consorted public-private partnership approaches to improve preclinical data quality – the perspective of the pharmaceutical industry

  • In: Symposium D2: Data quality, robustness and relevance in pre on Tuesday, 23 May 2017, 10:15-10:50
  • At: Stockholm (Sweden) (2017)
  • Type: Presentation
  • By: STECKLER, Thomas (Janssen R&D, Beerse, Belgium)
  • Co-author(s): Thomas Steckler: Bioresearch Quality & Compliance, Janssen R&D, Beerse, Belgium
    Malcolm Macleod: Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
  • Abstract:


    Pharmaceutical industry, as well as basic science, depend on robust data and scientific rigor as key drivers for decision making, patent strength and time-to-market, which in turn will determine knowledge gain and availability of new treatments to patients. Recent publications report challenges with the robustness, rigor, and/or validity of

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses